Halozyme Therapeutics Price to Free Cash Flow Ratio 2010-2024 | HALO
- Halozyme Therapeutics average price to free cash flow ratio for 2023 was 15.58, a 33.53% increase from 2022.
- Halozyme Therapeutics average price to free cash flow ratio for 2022 was 23.44, a 32.1% decline from 2021.
- Halozyme Therapeutics average price to free cash flow ratio for 2021 was 34.52, a 23.46% decline from 2020.
Price to free cash flow ratio can be defined as